Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 19/20 | 0.84 |
| ▸ | ADORA1 | P30542 | 9/20 | 0.84 |
| ▸ | ADORA2A | P29274 | 8/20 | 0.84 |
| ▸ | PPARG | P37231 | 1/20 | 0.84 |
| ▸ | PPARD | Q03181 | 1/20 | 0.84 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18675350 | 0.93 | ADORA3 (0.85) | ADORA3ADORA1ADORA2APPARGPPARD | |
| SCHEMBL19464991 | 0.92 | ADORA3 (0.84) | ADORA3ADORA1ADORA2APPARGPPARD | |
| SCHEMBL14316094 | 0.91 | ADORA3 (1.00) | ADORA3ADORA1ADORA2APPARGPPARD | |
| SCHEMBL12264930 | 0.91 | ADORA3 (1.00) | ADORA3ADORA1ADORA2APPARGPPARD | |
| SCHEMBL18675576 | 0.91 | ADORA3 (1.00) | ADORA3ADORA1ADORA2APPARGPPARD | |
| SCHEMBL18675652 | 0.91 | ADORA3 (0.83) | ADORA3ADORA1ADORA2APPARGPPARD | |
| SCHEMBL18675574 | 0.91 | ADORA3 (1.00) | ADORA3ADORA1ADORA2APPARGPPARD | |
| SCHEMBL5369617 | 0.91 | ADORA3 (1.00) | ADORA3ADORA1ADORA2APPARGPPARD | |
| SCHEMBL18675321 | 0.88 | ADORA3 (0.83) | ADORA3ADORA1ADORA2APPARGPPARD | |
| SCHEMBL14296866 | 0.84 | ADORA3 (0.86) | ADORA3ADORA1ADORA2APPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017052322-A1 | ADENOSINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING SAME AS ACTIVE INGREDIENT | 퓨쳐메디신 주식회사 | 2017-03-30 | — | — | WO | disclosed |